a. Multivariate Cox Regression for Survival, Factors available at treatment initiation only | |||
Variable set | Hazard ratio | 95Â % CI | p-value |
Extrahepatic metastases (yes) | 2.13 | 0.97 - 4.64 | 0.058 |
Liver volume (≥ 1376 mL) | 2.25 | 1.01 - 5.02 | 0.047 |
Maximum diameter of liver metastases (≥ 3.9 cm) | 3.12 | 1.39 - 7.02 | 0.006 |
Number of liver metastases (≥ 6) | 1.48 | 0.69 - 3.14 | 0.312 |
Lines of chemotherapy (≥ 3) | 2.48 | 1.15 - 5.36 | 0.021 |
Bone metastases only (yes) | 1.56 | 0.70 - 3.47 | 0.279 |
Liver volume (≥ 1376 mL) | 2.01 | 0.93 - 4.36 | 0.076 |
Maximum diameter of liver metastases (≥ 3.9 cm) | 3.1 | 1.37 - 7.02 | 0.007 |
Number of liver metastases (≥ 6) | 1.51 | 0.72 - 3.20 | 0.278 |
Lines of chemotherapy (≥ 3) | 2.6 | 1.14 - 5.92 | 0.023 |
b. Multivariate Cox Regression for Survival, All Factors (Pre- and Posttherapeutic) | |||
Variable set | Hazard ratio | 95Â % CI | p-value |
Extrahepatic metastases (yes) | 1.05 | 0.43 - 2.58 | 0.92 |
Liver volume (≥ 1376 mL) | 2.17 | 0.90 - 5.22 | 0.084 |
Maximum diameter of liver metastases (≥ 3.9 cm) | 3.1 | 1.31 - 7.36 | 0.01 |
Number of liver metastases (≥ 6) | 1.13 | 0.49 - 2.59 | 0.782 |
Lines of chemotherapy (≥ 3) | 1.81 | 0.83 - 3.97 | 0.138 |
Under local control in FU (yes) | 0.29 | 0.11 - 0.73 | 0.009 |
Best response overall (OR, RECIST) | 0.21 | 0.08 - 0.57 | 0.002 |
Bone metastases only (yes) | 1.06 | 0.46 - 2.44 | 0.89 |
Liver volume (≥ 1376 mL) | 2.16 | 0.92 - 5.03 | 0.075 |
Maximum diameter of liver metastases (≥ 3.9 cm) | 3.05 | 1.22 - 7.61 | 0.017 |
Number of liver metastases (≥ 6) | 1.12 | 0.48 - 2.59 | 0.796 |
Lines of chemotherapy (≥ 3) | 1.8 | 0.80 - 4.01 | 0.154 |
Under local control in FU (yes) | 0.29 | 0.12 - 0.70 | 0.006 |
Best response overall (OR, RECIST) | 0.21 | 0.08 - 0.52 | 0.001 |